BACKGROUND Polycystic ovary syndrome (PCOS) is the most common cause of
anovulatory infertility. An endometrial component has been suggested to contribute to …

Polycystic ovary syndrome (PCOS) is a very common endocrine and metabolic disorder with
the involvement of both genetic and environmental factors. Although much has been …

The aim of the available literature review was to focus on the role of the proinflammatory
mediators of AA and LA derivatives in pathological conditions related to reproduction and …

Infertility is an increasing problem that affects couples attempting pregnancy. A growing
body of evidence points to a link between diet and female fertility. In fact, data show that a …

Polycystic ovary syndrome (PCOS) is a disease in which endocrine metabolic abnormalities
coexist with reproductive system abnormalities, with the main clinical manifestations …

Myo-inositol has been established as an important growth-promoting factor of mammalian
cells and animals. The role of myo-inositol as a lipotropic factor has been proven, in addition …

Polycystic ovary syndrome (PCOS) is a heterogenous disorder characterized by chronic
ovulation dysfunction and hyperandrogenism. It is considered the most common …

This study aimed to evaluate the clinical manifestations and health risks associated with
polycystic ovary syndrome (PCOS) and its impact on quality of life (QOL) in Pakistan. A …

Polycystic ovary syndrome (PCOS), a multisystem disease, is a major reason for female
infertility around the world. It is no longer considered simply as a disease of ovary. Now …

Polycystic ovary syndrome (PCOS) is marked in 30 to 40% by insulin resistance and
hyperandrogenism. Myo-inositol (MI) increases insulin sensitivity, decreases …